Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series
Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...
Main Authors: | Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-06-01
|
Series: | CNS Oncology |
Subjects: | |
Online Access: | https://www.futuremedicine.com/doi/10.2217/cns-2019-0007 |
Similar Items
-
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab
by: Alissa Thomas, et al.
Published: (2018-01-01) -
A validated microRNA profile with predictive potential in glioblastoma patients treated with bevacizumab
by: Josie Hayes, et al.
Published: (2016-10-01) -
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
by: Patrick Roth, et al.
Published: (2020-06-01) -
Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study
by: Bai X, et al.
Published: (2024-11-01) -
Bevacizumab in recurrent WHO grades II–III glioma
by: Soufyan Annakib, et al.
Published: (2023-07-01)